+ Follow DR. JOSEPH FECZKO Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 453924
[Title] => In the business of saving lives
[Summary] => With today’s fast-paced lifestyle, the aphorism “health is wealth” is a relevant saying that one must take seriously. Apart from a sensible diet and exercise, one way to achieve this is to take safe and effective medicine.
[DatePublished] => 2009-04-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[1] => Array
(
[ArticleID] => 264972
[Title] => Who says only toothpaste stops plaque?
[Summary] => The cholesterol-lowering atorvastatin calcium has been shown to stop progression of plaque build-up in arteries. Patients taking atorvastatin experienced a significant reduction in the progression of atherosclerosis, or hardening of the arteries, compared to patients who received pravastatin, according to new data published in the Journal of the American Medical Association.
[DatePublished] => 2004-09-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
DR. JOSEPH FECZKO
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 453924
[Title] => In the business of saving lives
[Summary] => With today’s fast-paced lifestyle, the aphorism “health is wealth” is a relevant saying that one must take seriously. Apart from a sensible diet and exercise, one way to achieve this is to take safe and effective medicine.
[DatePublished] => 2009-04-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[1] => Array
(
[ArticleID] => 264972
[Title] => Who says only toothpaste stops plaque?
[Summary] => The cholesterol-lowering atorvastatin calcium has been shown to stop progression of plaque build-up in arteries. Patients taking atorvastatin experienced a significant reduction in the progression of atherosclerosis, or hardening of the arteries, compared to patients who received pravastatin, according to new data published in the Journal of the American Medical Association.
[DatePublished] => 2004-09-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
September 16, 2004 - 12:00am